CARNEGIE PHARMA Trademark

Trademark Overview

On Thursday, November 7, 2024, a trademark application was filed for CARNEGIE PHARMA with the United States Patent and Trademark Office. The USPTO has given the CARNEGIE PHARMA trademark a serial number of 98841106. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, May 13, 2025. This trademark is owned by Carnegie Pharmaceuticals LLC. The CARNEGIE PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements for humans; Glaucoma agents; Medicines for the treatment of gastrointestinal diseases; Nutritional supplements; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical products for the prevention and treatment of cancer; Thyroid and para-thyroid hormone preparations; Vitamin and mineral preparations for medical use
carnegie pharma

General Information

Serial Number98841106
Word MarkCARNEGIE PHARMA
Filing DateThursday, November 7, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, May 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of the wording Carnegie Pharma in a stylized. Surrounding the wording are two corner-like graphic elements, one on the upper right and the other on the lower left, each made up of intersecting thin lines arranged at right angles.
Goods and ServicesDietary supplements for humans; Glaucoma agents; Medicines for the treatment of gastrointestinal diseases; Nutritional supplements; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical products for the prevention and treatment of cancer; Thyroid and para-thyroid hormone preparations; Vitamin and mineral preparations for medical use
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCarnegie Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDelran, NJ 08075

Trademark Events

Event DateEvent Description
Thursday, November 7, 2024NEW APPLICATION ENTERED
Monday, May 5, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, May 5, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 6, 2025ASSIGNED TO EXAMINER
Tuesday, May 13, 2025NON-FINAL ACTION WRITTEN
Tuesday, May 13, 2025NON-FINAL ACTION E-MAILED
Tuesday, May 13, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

pharma carnegie preparations treatment pharmaceutical diseases disorders supplements substances gastrointestinal viral thyroid